Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07136025

The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Beijing Chao Yang Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Severe asthma is a complex and heterogeneous disease. Patients with severe asthma can present with different types of airway inflammation, and are often accompanied by a variety of comorbidities and risk factors. Identification of potentially modifiable factors affecting prognosis, that is, "treatable characteristics", and individualized bundle management based on these characteristics may help to improve the quality of life of patients with asthma and improve the level of asthma control. Through joint research, this project aims to evaluate the treatable characteristics of asthma in patients with severe asthma in tertiary hospitals across the country, including lung function, fractional exhaled nitric oxide, blood routine, allergen IgE, chest CT, and a detailed questionnaire. The distribution of treatable characteristics of patients with severe asthma and its impact on the quality of life or asthma control level of patients were investigated. For patients with severe asthma, multidisciplinary consultation and shared decision-making were used to establish an individualized bundle management model based on the treatable characteristics of severe asthma. A 6-month randomized parallel controlled clinical trial was conducted to determine whether this model was superior to conventional management in improving the quality of life or asthma control in patients with severe asthma. The implementation of this project will build a new model of individualized management of severe asthma based on treatable characteristics and improve the management level of severe asthma

Conditions

Interventions

TypeNameDescription
PROCEDUREIndividualized cluster managementIndividualized cluster management for treatable traits
PROCEDURERoutine asthma treatmentRoutine asthma treatment according to current guidelines

Timeline

Start date
2025-02-01
Primary completion
2029-01-31
Completion
2029-01-31
First posted
2025-08-22
Last updated
2025-08-22

Locations

10 sites across 1 country: China

Source: ClinicalTrials.gov record NCT07136025. Inclusion in this directory is not an endorsement.